A 91-year-old depressed woman had resistant hypertension despite a triple combination of antihypertensives, including a Ca-antagonist, an angiotensin receptor blocker, and a thiazide diuretic at optimal doses. She had hypokalemic metabolic alkalosis, elevated plasma cortisol and ACTH, and elevated urinary cortisol. The high-dose dexamethasone did not suppress the elevated ACTH and cortisol. The addition of spironolactone to her previous medications controlled and normalized hypertension, hypokalemia, and hormonal abnormalities within 4 months. Her blood pressure, serum electrolytes, and the hormonal states remained normalized for more than a year thereafter. Her depressed mental state also improved after spironolactone.
Introduction
Resistant hypertension is a common clinical problem and is defined as blood pressure that remains above the goal in spite of the concurrent use of 3 antiphertensive agents of different classes, 1 ideally being a diuretic, with all agents prescribed at optimal doses (1, 2). As older age is one of the strongest risk factors for uncontrolled hypertension, the incidence of resistant hypertension will likely increase as the population becomes more elderly (2) . However, the mechanisms for resistant hypertension in the aged are poorly understood. We report a case of resistant hypertension in an aged woman who presented with clinical features simulating ectopic ACTH syndrome and whose disease state disappeared in response to spironolactone. The possible role of corticoid receptor imbalance in the genesis of this clinical feature is discussed together with its implication in the management of hypertension in the aged. This report is in accordance with the guideline of the ethical committee at our institution.
Case Report
A 91-year-old woman was referred to our hospital because of resistant hypertension and hypokalemia. She had been diagnosed as hypertensive and had been taking antihypertensive drugs for more than 15 years. Three months before admission, her blood pressure had gradually risen to 190-200/70-80 mmHg despite the combined administration of efonidipine (40 mg/day), a Ca channel blocker, valsartan (160 mg/day), an angiotensin-receptor blocker, and trichlormethiazide (1 mg/day), a thiazide diuretic. She was also noted to have hypokalemia and metabolic alkalosis. She had been under mental stress, having trouble with her daughterin-law and had episodes of hallucination and delusion; she had taken etizolam (1.5 mg/day), a benzodiazepine sedative, preceding the recognition of resistant hypertension. Her The heart and respiratory sounds were normal. There was a mild pretibial edema. There were no physical signs of Cushing's syndrome such as facial rounding, obesity, and striae. Echocardiography revealed concentric left ventricular hypertrophy and normal ejection fraction (75%). Baseline laboratory data (Table 1) showed hypokalemia and metabolic alkalosis with the serum levels of K (2.4 mEq/L), chloride (89 mEq/L), HCO3 (32 mEq/L), and arterial pH 7.46. She had also a mild sign of inflammation with leukocyte count of 11,200/μL and Creactive protein (CRP) of 3.82 mg/L. Urinalysis was positive (+) for protein and the estimated glomerular filtration rate was reduced (36.6 mL/min/1.73 m 2 ). Fasting endocrinological data revealed suppressed plasma renin activity (0.1 ng/ mL/h) and aldosterone (25 pg/mL) and elevated cortisol (20.6 μg/dL), ACTH (84.0 pg/mL) and B-type natriuretic peptide (BNP) (316.6 pg/mL). Urinary free cortisol excretion was increased (168.2 μg/day), while that of aldosterone was suppressed (<1.3 μg/day). Serum cortisol (19.4 μg/dL) and ACTH (60.5 pg/mL) at midnight also were elevated. The high serum ACTH and cortisol were, however, not suppressed even with the high-dose of dexamethasone 8 mg/day for 2days (ACTH, 98.5 pg/mL and cortisol, 27.0 μg/dL, after dexamethasone). Studies of the brain with magnetic resonance imaging (MRI) and computed tomography (CT) gave no sign of tumor in the anterior pituitary and other regions. Chest and abdominal CT/MRI as well as whole body positron 18 fluorodeoxyglucose emission tomography were done in conjunction with the examination of tumor markers (AFP, CEA, CA19-9, and SCC) for possible tumors. However, no tumor could be detected with either the imaging examinations or the tumor markers.
T a b l e 1 . L a b o r a t o r y Da t a o n Ad mi s s i o n
To control hypertension and hypokalemia, spironolactone was added to her previous medications; the dosage was gradually increased from 25 to 75 mg/day. Thereafter, hypertension and hypokalemia were alleviated and finally normalized a month after the addition of spironolactone. Her body weight was reduced to 36.5 kg and edema disappeared. The doses of other antihypertensive drugs were then gradually reduced, and 4 months later the plasma levels of cortisol, ACTH, renin activity, and aldosterone were all normalized and that of BNP was markedly reduced, although the plasma levels of both cortisol and ACTH were further elevated in the first 1 week of spironolactone administration. The plasma levels of CRP also were normalized and her depressive mental state improved. Throughout 12 months after the administration of spironolactone, her blood pressure, serum K, urinary cortisol and aldosterone as well as plasma cortisol, ACTH, renin activity, and aldosterone remained within normal range, urinary protein disappeared, and depressive mental state was ameliorated (Fig. 1 ).
Discussion
The current case presented with hypertension which could not be controlled even with triple combination of Ca channel blocker, angiotensin receptor blocker, and thiazide diu- retics at the optimal doses. Her hypertension was associated with hypokalemia, metabolic alkalosis, and suppressed plasma renin and aldosterone. On the other hand, the plasma ACTH and cortisol were elevated both in the early morning and midnight and could not be suppressed even with a high dose of dexamethasone. Urinary excretion of free cortisol was also increased. All of these results supported the diagnosis of ACTH-dependent Cushing's syndrome due to either pituitary adenomas (Cushing's disease) or tumors causing the ectopic ACTH syndrome (4, 5) . Because the patient had no physical signs of Cushing's syndrome and the high dose dexamethasone test was negative, and thus ectopic ACTH syndrome rather than Cushing's disease was suspected, no further tests including CRH test and/or inferior petrosal sinus sampling for ACTH were done to exclude the possibility of Cushing's disease since the patient was too old and frail for possible surgical intervention. No tumors, however, could be detected with either the imaging examinations or tumor markers. Surprisingly, not only hypertension and hypokalemia, but also the elevated plasma ACTH and cortisol, urinary cortisol excretion, and suppressed plasma aldosterone and renin activity, were gradually improved and normalized within 4 months of the addition of spironolactone and remained stabilized throughout 1 year of observation, although the elevated plasma levels of ACTH and cortisol were further increased temporarily during the first week of spironolactone administration (Fig. 1) . Associated with these, her depressive mental state also improved and remained ameliorated without episodes of delusion. The ectopic ACTH syndrome is caused by ACTHsecreting tumors and can be either malignant or indolent, the former being rapidly progressive with extremely high ACTH and cortisol, and the latter associated with typical clinical and biochemical Cushing's syndrome (4, 5) . In the present case, the levels of ACTH and cortisol were modestly, but not extremely high and there were no physical signs of Cushing's syndrome. Furthermore, the disease state finally disappeared in response to spironolactone. Cushing's syndrome therefore could not be diagnosed in this case.
F i g u r e 1 . Cl i n i c a l c o u r s e o f t h e p a t i e n t . Af t e r t h e a d mi n i s t r a t i o n o f s p i r o n o l a c t o n e , e l e v a t e d b l o o d p r e s s u r e , h y p o k a l e mi a , e l e v a t e d p l a s ma ACT H a n d c o r t i s o l , a n d s u p p r e s s e d p l a s ma a l d o s t e ro n e a n d r e n i n we r e a l l e v i a t e d a n d / o r n o r ma l i z e d 4 mo n t h s l a t e r a n d r e ma i n e d s o f o r mo r e t h a n a y e a r , a l t h o u g h p l a s ma l e v e l s o f b o t h c o r t i s o l a n d ACT H we r e f u r t h e r e l e v a t e d i n t h e f i r s t we e k o f
It is noteworthy that the patient had been under stress and had been suffering from depression with episodes of delusion and cognitive impairment preceding the appearance of resistant hypertension. It is recognized that patients with depression, especially older women, may exhibit the hormonal abnormalities of patients with Cushing's syndrome and this state is known as pseudo-Cushing's state (4, 5) . Desmopressin test has been reported to be useful for differentiating this disorder from Cushing's disease (4). The recent guide-line for Cushing's syndrome however restricts this test to research studies only (5) and this test was not done in the patient. The fact that the hormonal abnormalities disappeared in response to spironolactone were considered to be compatible with the diagnosis of pseudo-Cushing state (4, 5) . Stress activates the hypothalamic-pituitary adrenal (HPA) axis resulting in an increase of cortisol secretion (6) and a chronically elevated cortisol increases vulnerability to depression and psychotic episodes in susceptible individuals (7, 8) . In such individuals increased HPA axis activity can result from an overactive hypothalamus and /or resistance to cortisol negative feedback (7) (8) (9) (10) .
Negative feedback regulation of the HPA axis is mediated through a dual-receptor system of mineralocorticoid receptors (MR) and glucocorticoid receptors (GR) in the brain (7-9, 11 ). MR has a high affinity and GR a low affinity for cortisol and their distribution also differs, with MR predominantly in limbic areas, particularly hippocampus, and GR more widely distributed across all brain regions (7-9, 11). GR is therefore believed to be more important in the response to stress when endogenous level of cortisol is high (7, 9) . Hyperactivity of the HPA axis is one of the most consistent findings in stress-related psychiatric disorders including major depression (10) and it is reported that there is a change in the differential responsiveness of the HPA axis to GR and MR, with increased MR signaling compensating for impaired GR function in severe depression (7, (9) (10) (11) (12) . It is therefore likely that the GR-mediated negative feedback in the brain and the HPA axis had been reduced or impaired, leading to the elevated HPA axis activity and cortisol levels, and thereby resulting in the compensatory enhanced activity of MR in this patient. The finding that the elevated ACTH and cortisol levels could not be suppressed with even a high-dose of dexamethasone, a GR antagonist, in conjunction with the fact that these elevated levels were further increased during the first week of spironolactone, an MR antagonist, supported this line of thinking and suggested an imbalance in MR/GR activities. Although GR and MR are synergistic in their effects on HPA axis inhibition, the effects of these receptors are antagonistic in the regulation of serotonin (5HT) activity in the brain: MR down-regulates and GR up-regulates serotonin activity (10, 11) . Major depression is accompanied by downregulation of serotonin activity in the brain (8, 11) . Thus, the increased ratio of MR/GR activation would be expected to down-regulate serotonin activity in the brain, resulting in depression in susceptible individuals (8, 11) . Indeed, antidepressants have been shown to enhance GR activity in the brain and thereby restore GR-mediated feedback inhibition on the HPA axis (8, 10, 11) . It is therefore likely that spironolactone improved the reduced GR and serotonin activities by blocking MR in the brain, and thereby alleviated depression in this patient. The results are thus in agreement with those of previous studies (11) (12) (13) . However, other mechanisms also might have been involved in the alleviation of depression after spironolactone in this patient.
MR has high affinity for both cortisol and aldosterone, whereas GR is selective for cortisol (14, 15) . In the epithelial tissues including the kidney, the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) is associated with MR and prevents action of cortisol by converting cortisol to the inert cortisone (14, 15) . Under conditions of excess cortisol, the activity of 11β-HSD2 is overwhelmed so that cortisol can activate MR (14, 16) . Cortisol can also activate MR under the conditions of impaired 11β-HSD2 activity, which include hereditary defects, licorice intake, chronic kidney disease, and inflammation (3, 14, 15, 17) . This patient had not taken licorice nor had a family history of similar disease. However, she had chronic kidney disease and inflammation. Accordingly, it is quite likely that hyperactivity of MR had been induced both by elevated cortisol and impaired 11β-HSD2, thereby resulting in resistant hypertension and hypokalemia in this patient (18) . It is also possible that elevated ACTH might have stimulated the synthesis of adrenal steroid intermediaries with mineralococorticoid activity (16) .
This line of thinking is consistent with the finding that the plasma renin as well as aldosterone was suppressed and BNP increased and that these abnormalities were corrected by spironolactone.
As the aged are typically exposed to chronic stress and inflammation and the sensitivity of the HPA axis to cortisol negative feedback is decreased with aging (19), the resulting chronic increase in cortisol exposure may damage the hippocampus and other regions of the limbic system which regulate the HPA axis and which are important to emotional and cognitive function (7) (8) (9) (10) . This may lead to a vicious cycle of further cortisol hypersecretion and damage to mechanisms regulating HPA feedback inhibition in the aged. Aging is also associated with chronic inflammation and kidney disease which may impair 11β-HSD2 activity (14, 17) . As older age is one of the strongest risk factors for uncontrolled-hypertension (2) , and the frequency of resistant hypertension will likely increase as the population becomes more elderly, it will be important to keep in mind the possibility of an imbalance of MR/GR in the pathogenesis and management of hypertension in the aged (2, 9, 21, 22) .
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